Virus-fighting drug's cost announced

Gilead Sciences said it will charge the U.S. government and other developed countries $390 per vial for its coronavirus-fighting drug remdesivir, or about $2,340 for a typical five-day course of treatment. Gilead said in a statement Monday it would offer this price to developed countries around the world to create a one-price model that would avoid the need for country-by-country negotiations that could slow access. "We wanted to make sure that nothing gets in the way of remdesivir getting to patients," Gilead Chief Executive Officer Daniel O'Day said in an...